4
Tetrahedron Letters
Diterpenoids (9) and (10) are highly ichthyotoxic12 and have
mg, 0.84 mmol), which was heated at reflux for 4 h. Then, the
mixture was washed twice with water, dried, and concentrated.
The crude reaction product (94 mg) was purified by silica gel
column chromatography (4 g, 1.5% AcOEt in petroleum ether) to
give methyl (8S,9R,13S,14R)-4,4,8,9,13-pentamethyl-20(109)-
abeo-ent-isocopal-5(10),11(12)-dien-15β-oate (5) (59 mg, 67%):
white gum; [α]D25 = 37.7 (c 1.33, CHCl3). IR liquid film (, cm-1):
1164, 1732. Anal. Calcd. for C21H32O2: C 79.70, H 10.19; found:
C 79.81, H 10.14. 1H and 13C NMR see Table 1.
demonstrated in vivo bioactivity as morphogens in the Hydra
tentacle regeneration assay and their parallel function as
activators of rat brain protein kinase C was also described.14
It should also be noted that the synthesis of terpenoids with
the verrucosin A and B carbon skeleton has not yet been
achieved. The biogenetic pathway leading to 9 and 10 has been
previously suggested15 and the present communication helps to
confirm it with additional synthetic data.
8.
(8S,9R,13S,14R)-4,4,8,9,13-Pentamethyl-20(109)-abeo-ent-
isocopal-5(10),11(12)-dien-15β-ol (6). A solution of ester (5) (10
mg, 0.032 mmol) in anhydrous THF (5 mL) was treated with
LiAlH4 (15 mg, 0.40 mmol) under stirring. After 3 h at reflux, the
reaction was cooled and quenched with ethyl acetate (0.1 mL).
The reaction product was subsequently treated with a 10% H2SO4
solution (2 mL), extracted with diethyl ether (3x2 mL) and washed
with brine, sat. NaHCO3 solution and brine. The diethyl ether
extract was dried over Na2SO4 for 2 h and then evaporated in
vacuo. The crude product was purified by flash chromatography
(silica gel (0.2 g, 1.5% AcOEt in petroleum ether) to give alcohol
In conclusion - the first biomimetic synthesis of methyl
(8S,9R,13R,14R)-4,4, 8,9,13-pentamethyl- 20(109)-abeo-ent-
isocopal-5(10),11(12)-dien-15-oate – a diterpenoid with the ent-
verrucosin A/B skeleton has been performed by electrophilic
isomerization of methyl 12-hydroxy-ent-isocopal-13(16)-en-15-
oate. The presented method opens the possibility of the synthesis
of bioactive diterpenoids possessing this unique rearranged
framework.
25
6 (9 mg, 98%). Colorless viscous oil. [α]D = 31.5 (c 0.61,
CHCl3). IR liquid film (, cm-1): 1360, 1460, 2925. 3375. 1H
NMR (400 MHz, CDCl3, H): 0.75 (s, 3H, H-17), 0.86 (s, 3H, H-
19), 0.907 (s, 3H, H-20), 0.91 (s, 3H, H-18), 0.99 (d, J = 7.0 Hz,
3H, H-16), 1.26 (td, J = 12.5, 3.3 Hz, 1H, H-3ax), 1.36 (dddd, J =
12.5, 5.1, 3.3, 1.3 Hz, 1H, H-3eq),1.39 (dt, J = 10.5, 3.6 Hz, 1H, H-
14ax), 1.43 (br. s, OH), 1.47 (m, 2H, H-2), 1.55 (m, J = 14.0, 12.6,
5.9 Hz, 1H, H-7ax), 1.63 (ddd, J = 14.0, 5.9, 1.7 Hz, 1H, H-7eq),
1.87 (m, 4H, H-1 and H-6), 2.03 (m, J = 10.5, 7.0, 1.6, 1.3 Hz, 1H,
H-13), 3.66 (dd, J = 11.5, 3.3 Hz, 1H, H-15A), 3.82 (dd, J = 11.5,
3.8 Hz, 1H, H-15B), 5.31 (dd, J = 10.1, 1.6 Hz, 1H, H-12), 5.35
(dd, J = 10.1, 1.3 Hz, 1H, H-11). 13C NMR (100 MHz, CDCl3, C):
19.6 (q, C-17), 20.0 (t, C-2), 20.2 (q, C-16), 21.2 (t, C-6), 22.5 (q,
C-20), 27.2 (t, C-1), 27.8 (q, C-18), 28.6 (t, C-7), 28.9 (q, C-19),
31.1 (d, C-13), 33.9 (s, C-4), 36.4 (s, C-8), 39.8 (t, C-3), 43.3 (s,
C-9), 45.0 (d, C-14), 62.9 (s, C-15), 130.6 (d, C-12), 131.2 (s, C-
5), 133.3 (s, C-11), 134.6 (d, C-10).
Acknowledgement
The financial support from Supreme Council for Science and
Technology Development of the Republic of Moldova (Project
"Elaboration of methods for obtaining valuable terpenoids by
valorization of renewable resources from the Republic of
Moldova, 2015-2018", No 15.817.02.14A) is gratefully
acknowledged.
References and Notes
1.
2.
(a) Hanson, J. R. Nat. Prod. Rep. 2015, 32, 1654-1663 and
previous reviews of this series; (b) González, M. A. Nat. Prod.
Rep. 2015, 32, 684-704.
9.
The calculated value of the J13ax,14ax coupling constant was 11.9
Hz. For molecular modeling with energy minimization, PERCH
NMR TOOLS (version 2014.1) software was used.
(a) Blunt, J. W.; Copp, B. R.; Keyzers, R. A.; Munro, M. H. G.;
Prinsep, M. R. Nat. Prod. Rep. 2015, 32, 116-211 and previous
reviews of this series; (b) Xie, Y.; Wright, S.; Shen, Y.; Du, L.
Nat. Prod. Rep. 2012, 29, 1277-1287; (c) Berrue, F.; Kerr, R.G.
Nat. Prod. Rep. 2009, 26, 681-710; (d) Keyzers, R. A.; Northcote,
P. T.; Davies-Coleman, M. T. Nat. Prod. Rep. 2006, 23, 321–334.
Barkhash, V. A.; Polovinka, M. P. Russ. Chem. Rev. 1999, 68,
393-414.
10. (a) Kim, S.-H.; Heo, K.; Chang, Y.-J.; Park, S.-H.; Rhee, S.-K.;
Kim, S.-U. J. Nat. Prod. 2006, 69, 758–762; (b) For a review on
biosynthesis via carbocations see: Tantillo, D. J. Nat. Prod. Rep.
2011, 28, 1035-1053.
11. Basabe, P.; Diego, A.; Díez, D.; Marcos, I. S.; Mollinedo, F.;
Urones, J.G. Synthesis 2002, (11), 1523-1529.
12. Cimino, G.; Gavagnin, M.; Sodano, G.; Puliti, R.; Mattia, C. A.;
Mazzarella, L. Tetrahedron 1988, 44, 2301-2310.
13. Zubia, E.; Gavagnin, M.; Crispino, A.; Martinez, E.; Ortea, J.;
Cimino, G. Experientia 1993, 49, 268-271.
14. (a) De Petrocellis, L.; Di Marzo, V.; Arca, B.; Gavagnin, M.;
Minei, R.; Cimino, G. Comp. Biochem. Physiol. 1991, 100C, 603-
607; (b) De Petrocellis, L.; Orlando, P.; Gavagnin, M.; Ventriglia,
M.; Cimino, G.; Di Marzo, V. Experientia 1996, 52, 874-877.
15. Gavagnin, M.; Ungur, N.; Castelluccio, F.; Cimino, G.
Tetrahedron 1997, 53, 1491-1504.
3.
4.
5.
Imamura, P. M.; Sierra, M. G.; Ruveda, E. A. J. Chem. Soc.,
Chem. Comm. 1981, 734-735.
(a) Hua, S.-K.; Wang, J.; Chen, X.-B.; Xu, Z.-Y.; Zeng, B.-B.
Tetrahedron 2011, 67, 1142-1144; (b) Vlad, P. F.; Ungur, N.;
Nguen, V. T. Russ. Chem. Bull. 1995, 44, 2404-2411.
Mischne, M. P.; Sierra, M. G.; Ruveda, E. A. J. Org. Chem. 1984,
49, 2035–2037.
6.
7.
Methyl (8S,9R,13R,14R)-4,4,8,9,13-pentamethyl- 20(109)-
abeo-ent-isocopal-5(10),11(12)-dien-15-oate (5). To a solution of
1 (95 mg, 0.28 mmol) in CHCl3 (35 mL) was added p-TsOH (145